Drug Discovery & Development | FDA Approves Merck's NOXAFIL® (posaconazole) Injection (18 mg/mL) for ... MarketWatch The administration of NOXAFIL with sirolimus, pimozide, quinidine,atorvastatin, lovastatin, simvastatin and ergot alkaloids must be avoided. When administered with NOXAFIL, some drugs such as cyclosporine and tacrolimus required dosage adjustments and ... FDA Approves Merck's NOXAFIL(R) (posaconazole) Injection (18 mg/mL) for ... |
